DSGN Earnings

Quarterly EPS
$-0.23
Q3 2024
$-0.24
Q4 2024
$-0.31
Q1 2025
$-0.34
Q2 2025
$-0.30
Q3 2025
$-0.27
Q4 2025
$-0.29
Q1 2026
$-0.32
Q2 2026
Latest RevenueN/A
Latest Net Income-20165000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.320-20165000+5.9%
Q1 2026-$0.290-17636000+6.5%
Q4 2025-$0.270-15997000-12.5%
Q3 2025-$0.300-16997000-30.4%
Q2 2025-$0.340-19083000-61.9%
Q1 2025-$0.310-17715000-55.0%
Q4 2024-$0.240-13651000-14.3%
Q3 2024-$0.230-13039000+17.9%
Q2 2024-$0.210-11793000
Q1 2024-$0.200-11105000
Q4 2023-$0.210-11842000
Q3 2023-$0.280-15789000
Design Therapeutics (DSGN) — Earnings